JG
TMDX icon

Joel Greenblatt’s Transmedics TMDX Stock Holding History

Joel Greenblatt’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,820
Closed -$3.76M – 1888
2026
Q1 		$3.76M Sell
37,820
-3,052
-7% -$398K 0.01% 942
2025
Q4 		$4.97M Buy
40,872
+32,635
+396% +$4.1M 0.02% 815
2025
Q3 		$924K Buy
8,237
+5,078
+161% +$594K ﹤0.01% 1221
2025
Q2 		$423K Buy
+3,159
New +$347K ﹤0.01% 1374
2024
Q3 		– Sell
-1,993
Closed -$300K – 1523
2024
Q2 		$300K Buy
+1,993
New +$239K ﹤0.01% 1225
2023
Q3 		– Sell
-18,727
Closed -$1.57M – 1410
2023
Q2 		$1.57M Sell
18,727
-10,532
-36% -$806K 0.03% 622
2023
Q1 		$2.22M Buy
29,259
+12,242
+72% +$847K 0.05% 482
2022
Q4 		$1.05M Buy
+17,017
New +$905K 0.03% 659

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Joel Greenblatt's TMDX Position: Q2 2026 in Review

Joel Greenblatt sold out of Transmedics (TMDX) in Q2 2026, closing a stake of 37,820 shares — an estimated $3.76M sold.

Joel Greenblatt first reported a position in TMDX in Q4 2022 and held it in 8 quarters. The position peaked at $4.97M in Q4 2025. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Joel Greenblatt reported no remaining Transmedics position as of Q2 2026 after selling out during the quarter.
  • Joel Greenblatt sold 37,820 Transmedics shares in Q2 2026, an estimated $3.76M.
  • Joel Greenblatt first reported a position in Transmedics in Q4 2022 and held it in 8 quarters.
  • Joel Greenblatt's Transmedics position peaked at $4.97M in Q4 2025.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.